Clinical outcome (CO) and predictive factors (PRE) evaluation of a cohort of castration resistant prostate cancer (CRPC) patients (pts) treated with abiraterone acetate (AA) in a named patient program (NPP): Preliminary results from a retrospective study.
Antonello Veccia
No relevant relationships to disclose
Lucia Fratino
No relevant relationships to disclose
Umberto Basso
No relevant relationships to disclose
Maddalena Donini
No relevant relationships to disclose
Alessandro D'Angelo
No relevant relationships to disclose
Francesco Massari
No relevant relationships to disclose
Giuseppe Procopio
No relevant relationships to disclose
Donatello Gasparro
No relevant relationships to disclose
Francesco Verderame
No relevant relationships to disclose
Caterina Messina
No relevant relationships to disclose
Fable Zustovich
No relevant relationships to disclose
Roberto Iacovelli
No relevant relationships to disclose
Anna Paola Fraccon
No relevant relationships to disclose
Giovanni L. Pappagallo
No relevant relationships to disclose
Francesca Maines
No relevant relationships to disclose
Orazio Caffo
No relevant relationships to disclose
Enzo Galligioni
No relevant relationships to disclose